Hakan EKMEKÇİ, Suat Hayri KÜÇÜK, Yunus KARAKOÇ2, Muharrem ÇİDEM, Şafak Sahir KARAMEHMETOĞLU, Kerem GÜN, İlhan KARACAN, Murat ULUDAĞ

Effects of whole-body vibration on plasma sclerostin level in healthy women*

Background/aim: To determine whether plasma sclerostin levels are affected by applying whole-body vibration treatments. Materials and methods: Following a pilot study, the present prospective, randomized, controlled single-blind study was performed on 16 healthy volunteer women (ages 20 to 40 years). Subjects were randomly divided into 2 groups, and whole-body vibration was applied to the treatment group but not to the controls. The plasma sclerostin levels were measured before the treatment and at the 10th minute after whole-body vibration on the 1st, 2nd, and 5th days of application. Results: The plasma sclerostin level measured at 10 min after the whole-body vibration treatment increased 91% (P = 0.024) on the 1st day and decreased 31.5% (P = 0.03) on the 5th day in the whole-body vibration group. In the control group, there was no change in the plasma sclerostin level at any time. A progressive increase in baseline plasma sclerostin levels during the 5 days of vibration sessions was also found. Conclusion: Our study demonstrated that whole-body vibration can change plasma sclerostin levels, and that this change is detectable 10 min after whole-body vibration treatments.

PDF

___

1. Gaudio A, Pennisi P, Bratengeier C, Torrisi V, Lindner B, Mangiafico RA, Pulvirenti I, Hawa G, Tringali G, Fiore CE. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab 2010; 95: 22482253.
2. Robling AG, Niziolek PJ, Baldridge LA, Condon KW, Allen MR, Alam I, Mantila SM, Gluhak-Heinrich J, Bellido TM, Harris SE et al. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem 2008; 283: 58665875.
3. Lombardi G, Lanteri P, Colombini A, Mariotti M, Banfi G. Sclerostin concentrations in athletes: role of load and gender. J Biol Regul Homeost Agents 2012; 26: 157163.
4. Lin C, Jiang X, Dai Z, Guo X, Weng T, Wang J, Li Y, Feng G, Gao X, He L. Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling. J Bone Miner Res 2009; 24: 16511661.
5. Mödder UI, Hoey KA, Amin S, McCready LK, Achenbach SJ, Riggs BL, Melton LJ, Khosla S. Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. J Bone Miner Res 2011; 26: 373379.
6. Moustafa A, Sugiyama T, Saxon LK, Zaman G, Sunters A, Armstrong VJ, Javaheri B, Lanyon LE, Price JS. The mouse fibula as a suitable bone for the study of functional adaptation to mechanical loading. Bone 2009; 44: 930935.
7. Suva LJ. Sclerostin and the unloading of bone. J Bone Miner Res 2009; 24: 16491650.
8. Mirza FS, Padhi ID, Raisz LG, Lorenzo JA. Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women. J Clin Endocrinol Metab 2010; 95: 19911997.
9. Cullen DM, Smith RT, Akhter MP. Bone-loading response varies with strain magnitude and cycle number. J Appl Physiol 2001; 91: 19711976.
10. Torcasio A, van Lenthe GH, Van Oosterwyck H. The importance of loading frequency, rate and vibration for enhancing bone adaptation and implant osseointegration. Eur Cell Mater 2008; 16: 5668.
11. Nikander R, Kannus P, Rantalainen T, Uusi-Rasi K, Heinonen A, Sievänen H. Cross-sectional geometry of weight-bearing tibia in female athletes subjected to different exercise loadings. Osteoporos Int 2010; 21: 16871694.
12. Yang PF, Brüggemann GP, Rittweger. What do we currently know from in vivo bone strain measurements in humans? J Musculoskelet Neuronal Interact 2011; 11: 820.
13. Ott SM. Sclerostin and Wnt signaling--the pathway to bone strength. J Clin Endocrinol Metab 2005; 90: 67416743.
14. Nicolella DP, Moravits DE, Gale AM, Bonewald LF, Lankford J. Osteocyte lacunae tissue strain in cortical bone. J Biomech 2006; 39: 17351743.
15. Hacyan S. What does it mean to modify or test Newtons second law? Am J Phys 2009; 77: 607609.
16. Rubin CT, McLeod KJ. Promotion of bony ingrowth by frequency-specific, low-amplitude mechanical strain. Clin Orthop Relat Res 1994; 298: 165174.
17. Montgomery R, Conway TW, Spector AA. Biochemistry: A Case-Oriented Approach. 6th ed. St. Louis, Mo, USA: C.V. Mosby Company; 1996.
18. Price C, Zhou X, Li W, Wang L. Real-time measurement of solute transport within the lacunar-canalicular system of mechanically loaded bone: direct evidence for load-induced fluid flow. J Bone Miner Res 2011; 26: 277285.
19. Lohman EB 3rd, Petrofsky JS, Maloney-Hinds C, BettsSchwab H, Thorpe D. The effect of whole body vibration on lower extremity skin blood flow in normal subjects. Med Sci Monit 2007; 13: CR71-6.
20. Kerschan-Schindl K, Grampp S, Henk C, Resch H, Preisinger E, Fialka-Moser V, Imhof H. Whole-body vibration exercise leads to alterations in muscle blood volume. Clin Physiol 2001; 21: 377382.
21. Sun YQ, McLeod KJ, Rubin CT. Mechanically induced periosteal bone formation is paralleled by the upregulation of collagen type one mRNA in osteocytes as measured by in situ reverse transcript-polymerase chain reaction. Calcif Tissue Int 1995; 57: 456462.
22. Judex S, Rubin CT. Is bone formation induced by highfrequency mechanical signals modulated by muscle activity? J Musculoskelet Neuronal Interact 2010; 10: 311.
23. Mödder UI, Clowes JA, Hoey K, Peterson JM, McCready L, Oursler MJ, Riggs BL, Khosla S. Regulation of circulating sclerostin levels by sex steroids in women and in men. J Bone Miner Res 2011; 26: 2734.
24. Tian X, Jee WS, Li X, Paszty C, Ke HZ. Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model. Bone 2011; 48: 197201.
25. Padhi D, Jang G, Stouch B, Fang L, Posvar E. Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody. J Bone Miner Res 2011; 26: 1926.
26. Kargotich S, Goodman C, Keast D, Morton AR. The influence of exercise-induced plasma volume changes on the interpretation of biochemical parameters used for monitoring exercise, training and sport. Sports Med 1998; 26: 101117.
27. Cardinale M, Soiza RL, Leiper JB, Gibson A, Primrose WR. Hormonal responses to a single session of whole-body vibration exercise in older individuals. Br J Sports Med 2010; 44: 284288.
28. Fricke O, Semler O, Land C, Beccard R, Thoma P, Schoenau E. Hormonal and metabolic responses to whole body vibration in healthy adults. Endocrinologist 2009; 19: 2430.
29. Martin RM, Correa PH. Bone quality and osteoporosis therapy. Arq Bras Endocrinol Metabol 2010; 54: 186199.
30. Briot K, Cortet B, Thomas T, Audran M, Blain H, Breuil V, Chapuis L, Chapurlat R, Fardellone P, Feron JM et al. 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis. Joint Bone Spine 2012; 79: 304313.
31. Uğurlu M, Yılmaz S, Deveci A, Ünlü S, Tunç B, Üstü Y, Sayıt E, Sanisoğlu SY. The epidemiologic characteristics of patients that underwent surgery for hip fracture. Turk J Med Sci 2012; 42: 299305.